Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AI/ML InnovationsAIMLF -1.17% Debt-to-Equity is 0.72 as of Jan. 2026. The stock has 4 warning signs investors should review. Among 558 Healthcare Providers & Services companies, AI/ML Innovations ranks worse than 64.7% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for AI/ML Innovations's Debt-to-Equity or its related term are showing as below:
AIMLF'
s Debt-to-Equity Range Over the Past 10 Years
Min: -19.09 Med: -0.22 Max: 0.73
Current: 0.72
During the past 13 years, the highest Debt-to-Equity Ratio of AI/ML Innovations was 0.73. The lowest was -19.09. And the median was -0.22.
AIMLF's Debt-to-Equity is ranked worse than 64.7% of 558
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs AIMLF: 0.72
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
AI/ML Innovations Debt-to-Equity Related Terms
AI/ML Innovations Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for AI/ML Innovations's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIMLF vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, AI/ML Innovations's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AI/ML Innovations Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AI/ML Innovations's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where AI/ML Innovations's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AI/ML Innovations (AIMLF) has a Debt-to-Equity of 0.72 as of Jan. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on AI/ML Innovations and its competitors. According to the industry distribution chart, AI/ML Innovations ranks #361 out of 558 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is AI/ML Innovations' Debt-to-Equity too high?
AI/ML Innovations' current Debt-to-Equity is 0.72. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. AI/ML Innovations' value of 0.72 is 71.4% above this industry median. Based on the distribution chart, AI/ML Innovations ranks #361 out of 558 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does AI/ML Innovations' Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, AI/ML Innovations ranks #361 out of 558 companies for Debt-to-Equity. This places AI/ML Innovations in the lower half of its industry. The industry median Debt-to-Equity is 0.42. AI/ML Innovations' value of 0.72 is 71.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AI/ML Innovations's current Debt-to-Equity of 0.72 is 71.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on AI/ML Innovations and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AI/ML Innovations's current Debt-to-Equity is 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AI/ML Innovations stock overvalued right now?
Based on GuruFocus' analysis, AI/ML Innovations (AIMLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.03 — trading 239% above its estimated fair value. The current Debt-to-Equity is 0.72 and 71.4% above the Healthcare Providers & Services industry median of 0.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For AI/ML Innovations (AIMLF), the current Debt-to-Equity is 0.72 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AI/ML Innovations Inc is a holding company. The company along with its subsidiaries is engaged in the research and development of health and wearable technologies, and the sale of licenses and consulting services related to those technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIMLF has been successfully added to your 
